AGARWALEYE Dr. Agarwal's Health Care Q2 FY26 results (Jul–Sep 2025) and concall
Dr. Agarwal's Health Care Limited reported a strong Q2 and H1 FY26, with H1 total income surpassing INR1,000 crores for the first time, growing 20.2% YoY to INR1,007 crores. Profitability saw significant improvement, with H1 EBITDA growing 24.9% to INR285 crores and PAT surging 88.4% to INR75 crores, driven by cost efficiencies and premiumization of services. The company continued its network expansion, adding 24 new Greenfield facilities, though growth in the North region was tempered by seasonal factors.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 21.2%, net profit up 225.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 255 | 268 | 281 | 302 | 309 +21% |
| EBITDA | 58 | 65 | 73 | 67 | 69 +19% |
| Net profit | -4 | 8 | 27 | 10 | 5 +225% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
